150 results on '"Bhanji, Rahima"'
Search Results
2. Physical Frailty and Sarcopenia in End-Stage Liver Disease: Do They Improve After Liver Transplantation?
3. De novo and recurrent liver disease
4. Sarcopenia in cirrhosis: from pathogenesis to interventions
5. Exception points for liver transplantation: A Canadian review
6. Physical Frailty and Sarcopenia in End-Stage Liver Disease: Do They Improve After Liver Transplantation?
7. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
8. The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist
9. Ethnic Disparities in the Prognosis of Cirrhosis
10. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis
11. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
12. COVID-19 infection in liver transplant recipients: Clinical features and outcomes from a Canadian multicentre cohort
13. Heal-me PiONEer (personalized online nutrition and exercise): An RCT assessing 2 levels of app-based programming in individuals with chronic disease
14. Skeletal muscle pathological fat infiltration (myosteatosis) associates with higher mortality in patients with cirrhosis
15. Inclusion of body composition parameters in MELD score leads to optimization of predictive performance in patients with cirrhosis
16. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
17. Fatty allograft and cardiovascular outcomes after liver transplantation
18. Post-transplant diabetes mellitus in Canadian liver and renal transplant recipients
19. The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change
20. Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis
21. Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions
22. Association between gut colonization of vancomycin‐resistant enterococci and liver transplant outcomes
23. Learning from a rare phenomenon — spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report
24. Post liver transplantation chronic kidney disease is associated with increased cardiovascular disease risk and poor survival
25. Hyperhomocysteinemia is associated with severity of cirrhosis and negative impact after liver transplantation
26. Serum Lipid Profiles and Risk of Cardiovascular Disease in Three Different Male Populations in Northern Nigeria
27. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies
28. Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre Cohort
29. Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation
30. Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation
31. Mo1590 STATIN USE IN LIVER TRANSPLANT: INDICATION, USE, AND IMPACT OF STATIN THERAPY ON PATIENT OUTCOMES
32. Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis
33. Liver transplantation for overlap syndromes of autoimmune liver diseases
34. Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre Cohort.
35. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis
36. Reliable Measures of Sarcopenia in Cirrhosis. Comment on: “The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097”
37. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis
38. Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease
39. SAT504 - Skeletal muscle pathological fat infiltration (myosteatosis) associates with higher mortality in patients with cirrhosis
40. Mo1859 – Does a Positive Clostridiodes Difficile Result Using Immunoassay Based Toxin Assay Versus Pcr for Toxin B Gene Lead to Differential Outcomes Among Patients with Inflammatory Bowel Disease?
41. The evolution and impact of sarcopenia pre- and post-liver transplantation
42. Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease
43. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis
44. Reply
45. Tu1499 - Sarcopenia as a Predictor of Outcomes in Patients following Liver Transplantation for Hepatocellular Carcinoma
46. Skeletal Muscle Abnormalities Increase the Risk of Overt Hepatic Encephalopathy and Hyperammonemia in Patients With Cirrhosis
47. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis.
48. Hyperhomocysteinemia is associated with severity of cirrhosis and negative impact after liver transplantation
49. Cirrhotic Patients With Sarcopenia and Sarcopenic-Obesity Have an Increased Risk of Hyperammonemia and Hepatic Encephalopathy Presidential Poster
50. Early Kidney Dysfunction After Liver Transplantation Is Associated With Reduced Graft and Patient Survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.